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Background: High density lipoproprotein (HDL) levels are associated with target vessel revascularization (TVR) and major adverse cardiovascular 
events (MACE) in the pre- drug-eluting stents (DES) era. Whether this association holds true with DES is unknown.
Methods: Patients who received DES at Mayo Clinic between 4/1/2003 and 6/30/2008 and had a HDL value were included. The primary 
endpoint was TVR and the secondary endpoint was MACE [cardiovascular death, myocardial infarction (MI) or TVR]. Multiple Cox proportional 
hazards analyses were performed for both endpoints to estimate the HDL effect, while adjusting for multiple clinical and angiographic factors. 
Interactions between HDL and diabetes and low density lipoproprotein (LDL) were also tested for both endpoints.
Results: 3780 patients met inclusion criteria. During median follow-up of 3 years, there were 287 TVR and 508 MACE events. Levels of HDL were 
not associated with TVR (adjusted HR, 1.0; 95% CI, 0.91-1.10; p = 0.98) or MACE (adjusted HR, 1.03; 95% CI, 0.96-1.1; p = 0.41). Three-year event 
rates by HDL quartiles are depicted in the Table. There was also no significant interaction between HDL and diabetes (p=0.97 for TVR, p=0.67 for 
MACE) or HDL and LDL (p=0.25 and p=0.34, respectively).
Conclusion: In this contemporary observational study of DES we found that HDL levels were not associated with either TVR or MACE. This lack of 
association held regardless of LDL levels or diabetes.
Table: Three-year Kaplan-Meier event rate estimates by high density lipoprotein quartiles.
Clinical outcome
HDL: 07-37
(N=987)
HDL: 38-44
(N=931)
HDL: 45-53
(N=920)
HDL: 54-164
(N=942)
P-value
Gender & Age
Adjusted
P-Value
Target vessel revascularization
KM (95% CI)
0.12
(0.09 - 0.14)
0.07
(0.05 - 0.09)
0.08
(0.06 - 0.10)
0.10
(0.07 - 0.12)
0.56 0.79
Cardiovascular death, myocardial 
infarction or target vessel 
revascularization
KM (95% CI)
0.18
(0.15 - 0.21)
0.14
(0.11 - 0.17)
0.15
(0.12 - 0.17)
0.16
(0.13 - 0.19)
0.56 0.41
